Bionomics (Bionomics) EBIT per Share : $0.00 (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Bionomics EBIT per Share?

Bionomics's EBIT per Share for the three months ended in Dec. 2023 was $0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00.

During the past 3 years, the average EBIT per Share Growth Rate was -12.20% per year. During the past 5 years, the average EBIT per Share Growth Rate was 14.40% per year. During the past 10 years, the average EBIT per Share Growth Rate was 6.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Bionomics's EBIT per Share or its related term are showing as below:

BNOX' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -81.7 Med: 5.75 Max: 33.9
Current: -12.2

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Bionomics was 33.90% per year. The lowest was -81.70% per year. And the median was 5.75% per year.

BNOX's 3-Year EBIT Growth Rate is ranked worse than
68.12% of 1311 companies
in the Biotechnology industry
Industry Median: 3.7 vs BNOX: -12.20

Bionomics's EBIT for the three months ended in Dec. 2023 was $0.00 Mil.

Bionomics EBIT per Share Historical Data

The historical data trend for Bionomics's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bionomics EBIT per Share Chart

Bionomics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

EBIT per Share

Get a 7-Day Free Trial

-1.71

-0.97

-1.36

-2.05

-2.64

Bionomics Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23
EBIT per Share	Get a 7-Day Free Trial															-	-	-	-	-

Bionomics EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Bionomics's EBIT per Share for the fiscal year that ended in Jun. 2023 is calculated as

	EBIT per Share		(A: Jun. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-21.498	/	8.160
=	-2.63

Bionomics's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	0	/	9.487
=	0.00

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00

Bionomics (NAS:BNOX) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Bionomics EBIT per Share Related Terms

Thank you for viewing the detailed overview of Bionomics's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Bionomics (Bionomics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bionomics Ltd (NAS:BNOX) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

B1N0:Germany

Address

200 Greenhill Road, Eastwood, SA, AUS, 5063

Website

https://www.bionomics.com.au

Bionomics Ltd is a global, clinical-stage biopharmaceutical company. It is primarily engaged in the development of therapeutics for diseases of the central nervous system and cancer. The company's reportable segment is the Drug Discovery and Development segment which is engaged in the discovery, development, and commercialization of compounds to match a target product profile. The company generates all of its revenues from Australia.